Direct Oral Anticoagulants, Bleeding Risk in Patients with Atrial Fibrillation, CHADS2 ≥ 3 or HAS-BLED ≥ 3

Acanfora D^1*, Casucci G², Ciccone MC³, Scicchitano P³, Montefusco G¹, Lanzillo A¹, Acanfora C¹ and Lanzillo B¹

¹Institute of Care and Scientific Research, Rehabilitation Institute of Telese Terme, Benevento, Italy

²San Francesco Hospital-TeleseTerme (BN), Italy

³Department of Emergency and Organ Transplantation, Section of Cardiovascular Diseases, University of Bari, School of Medicine, Bari, Italy